Complete FDA and NHTSA recall records dated in December 2024.
These records include useful source details for the selected month.
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
Undeclared Yellow #5 and Yellow #6
Patulin. Apple Cider was found to have elevated levels of patulin after receiving analytical testing results from 3rd party laboratory. Lab sample detected 78 ppb; limit is 50 ppb.
Meal kits contain cooked chicken which was recalled due to contamination with Listeria monocytogenes
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
Meal kits contain cooked chicken which was recalled due to contamination with Listeria monocytogenes
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
cGMP Deviations: Out of specification results for micro in hand soap products.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Presence of Particulate Matter: Potential for glass delamination from the vials.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Out of specification results for micro in hand soap products.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
Labeling: Not Elsewhere Classified - Wrong NDC number
Presence of Particulate Matter: Potential for glass delamination from the vials.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
Presence of Particulate Matter: Potential for glass delamination from the vials.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
